BIOL

Biolase, Inc.
BIOL

Overview Fund Activity
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

47 hedge funds and large institutions have $27.4M invested in Biolase, Inc. in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.

Holders
47
Holders Change
-1
Holders Change %
-2.08%
% of All Funds
1.26%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
5
Increased
10
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$69K
2
BIP
2
Brandes Investment Partners
California
$27K
3
Northern Trust
3
Northern Trust
Illinois
$104K
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$15K
5
TRCT
5
Tower Research Capital (TRC)
New York
$15K

Top Sellers

1
VKH
1
Virtu KCG Holdings
New York
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$16K
3
Nomura Holdings
3
Nomura Holdings
Japan
$0
4
TSS
4
Two Sigma Securities
New York
$0
5
LPL Financial
5
LPL Financial
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
KF
51
Krilogy Financial
Missouri
$0 3 – –
IWM
52
Integrated Wealth Management
California
$0 215 – –
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
$0 6 +6 New
1 2
3